Login / Signup

Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma.

Thomas PowlesDaniel P PetrylakJonathan E Rosenberg
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Keyphrases
  • dna damage
  • squamous cell carcinoma
  • small cell lung cancer
  • locally advanced
  • cell cycle
  • human health
  • risk assessment
  • cell proliferation
  • rectal cancer